With extensive research and observation, scientists have been able to obtain several insights about the novel coronavirus. These insights have enabled treatment of patients with mild and severe COVID-19. However, despite the achievements, several doors remain unopened. In an attempt to explore these, scientists have recently tried to decipher the mechanisms behind COVID-19 disease progression.
They obtained some interesting and game-changing results. A recent study published in the journal Cell Systems has leveraged proteomics to find out the differences in the blood samples of patients with mild and severe COVID-19. The researchers used the ultra-high-throughput serum and plasma proteomics to screen 31 patients with COVID-19. As a result, they could identify 27 potential biomarkers that are differentially expressed in patients at different stages of the disease , as per the WHO…
